This is a routine initial ownership filing by an executive chair. No trading activity or change in position is reported. Monitor future Form 4 filings for any insider transactions that could signal management's view of the stock.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Oct 29 $14.89entry
- T+1 · 6d ago −12.42%α −11.95% · $13.04
- T+5 · due 11h ago Pending
- T+5 · todayOpen
- T+20 · in 22d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Faheem Hasnain, Executive Chair of Aspen Neuroscience, filed an initial statement of beneficial ownership (Form 3) disclosing direct and indirect holdings including common stock, convertible preferred shares, and stock options. The filing is a routine insider onboarding requirement with no material new information about the company's operations or financials.
Key Facts
- Faheem Hasnain is Executive Chair of Aspen Neuroscience, Inc.
- Hasnain directly owns 26,658 shares of common stock.
- Hasnain indirectly owns 14,913 shares (Series A-1 preferred), 14,316 shares (Series A-2 preferred), and 7,120 shares (Series C preferred) through the Hasnain Revocable Trust, each convertible to common on a 1-for-9.8821 basis upon IPO completion.
- Hasnain holds options to buy 27,322 shares at $7.71 (fully vested, expires 2032-06-15) and 41,489 shares at $5.74 (vesting through 2031-11-20, expires 2035-11-25).
- A Power of Attorney was filed authorizing Jeffrey Boerneke to act on Hasnain's behalf for SEC filings.
Financial Impact
No financial impact; the filing discloses existing beneficial ownership without any transaction or change in position.
Risk Factors
- No material risks identified from this filing.
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-439140 |
| Document: 0001193125-26-439140-index-headers.html | 0001193125-26-439140 |
| Document: 0001193125-26-439140-index.html | 0001193125-26-439140 |
| Document: 0001193125-26-439140.txt | 0001193125-26-439140 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Nov 3, 2026 2d ago | SC 13G | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 2d ago | Insider Cluster | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Nov 2, 2026 3d ago | 8-K | $12.29 $12.76 | ▲ +3.82% | ▲ +2.17% | $11.76 (−4.31%) |
Oct 30, 2026 6d ago | 424B4 | $13.04 $12.29 | ▼ −5.75% | ▼ −6.05% | $11.76 (−9.82%) |
Oct 30, 2026 6d ago | EFFECT | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | Press Release | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
Oct 29, 2026 6d ago | 3 | $14.89 $13.04 | ▼ −12.42% | ▼ −11.95% | $11.76 (−21.02%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers